Copyright
©The Author(s) 2015.
World J Gastrointest Pharmacol Ther. Nov 6, 2015; 6(4): 172-182
Published online Nov 6, 2015. doi: 10.4292/wjgpt.v6.i4.172
Published online Nov 6, 2015. doi: 10.4292/wjgpt.v6.i4.172
Table 1 Causes of upper gastrointestinal bleeding
| Peptic ulcer | |
| Oesophagitis | |
| Drug-induced mucosal damage (NSAID) | Ulcer |
| Erosion | |
| Traumatic or postoperative lesions | Mallory-Weiss lesion |
| Arterio-intestinal fistula | |
| Malignant tumor | |
| Sequelae of portal hypertension | Oesophageal varices |
| Varices of the gastric fundus | |
| Portal hypertensive gastropathy | |
| Vascular anomalies | Dieulafoy lesion |
| Gastric antral vascular ectasia (GAVE syndrome) | |
| Angiodysplasia | |
| Rendu-Osler-Weber syndrome (hereditary hemorrhagic telangiectasia) | |
| Bleeding from the hepato-pancreatico-biliary system | |
| Bleeding from a duodenal diverticulum |
Table 2 Glasgow-Blatchford Score[10]
| Admission risk marker | Score component value |
| Blood urea (mmol/L) | |
| 6.5-8.0 | 2 |
| 8.0-10.0 | 3 |
| 10.0-25 | 4 |
| > 25 | 6 |
| Haemoglobin (g/dL) for men | |
| 12.0-12.9 | 1 |
| 10.0-11.9 | 3 |
| < 10.0 | 6 |
| Haemoglobin (g/dL) for women | |
| 10.0-11.9 | 1 |
| < 10.0 | 6 |
| Systolic blood pressure (mmHg) | |
| 100-109 | 1 |
| 90-99 | 2 |
| < 90 | 3 |
| Other markers | |
| Pulse ≥ 100 (per minute) | 1 |
| Presentation with melaena | 1 |
| Presentation with syncope | 2 |
| Liver disease | 2 |
| Cardiac failure | 2 |
Table 3 Clinical (pre endoscopy) and full (post endoscopy) Rockall score[11]
| Variable | Score 0 | Score 1 | Score 2 | Score 3 |
| Age | < 60 | 60-79 | ≥ 80 | |
| Shock | No shock | Pulse ≥ 100 | Systolic blood pressure < 100 | |
| Systolic blood pressure ≥ 100 | ||||
| Co-morbidity | Non major | Chronic heart failure, ischemic heart disease, major comorbidity | Renal failure, liver failure, metastatic cancer | |
| Diagnosis | Mallory-Weiss lesion | All other diagnoses | GI malignancy | |
| Evidence of bleeding | None | Blood, adherent clot, visible or spurting vessel |
Table 4 Forrest classification[12] and the risk of re-bleeding within 24 h after exclusively medical therapy
| Re-bleeding risk (%) | |
| Acute bleeding | |
| Forrest I a (spurting bleeding) | 90 |
| Forrest I b (oozing bleeding) | 50 |
| Signs of recent bleeding | |
| Forrest II a (visible vessel) | 25-30 |
| Forrest II b (adherent clot) | 10-20 |
| Forrest II c (flat pigmented haematin on ulcer base) | 7-10 |
| Lesions without active bleeding | |
| Forrest III (lesions without signs of recent bleeding or fibrin-covered clean ulcer base) | 3-5 |
- Citation: Biecker E. Diagnosis and therapy of non-variceal upper gastrointestinal bleeding. World J Gastrointest Pharmacol Ther 2015; 6(4): 172-182
- URL: https://www.wjgnet.com/2150-5349/full/v6/i4/172.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v6.i4.172
